Unlocking Alzheimer’s Mysteries: How PHGDH Changes the Game Alzheimer’s disease remains one of the most challenging neurodegenerative conditions, particularly in its late-onset form (LOAD), which strikes millions without clear genetic risk factors. Recent rese... Alzheimer's amyloid-beta biomarkers neurodegeneration PHGDH therapeutics transcriptional regulation
How Open-Source AI Is Revolutionizing Drug Discovery with TxGemma AI Accelerates Drug Development The traditional path to new medicines is slow, expensive, and fraught with risk. Now, with Google DeepMind’s open-source TxGemma models, there’s a seismic shift in how ... AI biotechnology DeepMind drug discovery open source therapeutics TxGemma